Spectrum Pharmaceuticals, Inc.

NASDAQ:SPPI   3:59:55 PM EDT
0.43
-0.21 (-33.01%)
Products

Spectrum Pharmaceuticals Receives FDA Approval For Rolvedon Injection

Published: 09/09/2022 20:26 GMT
Spectrum Pharmaceuticals, Inc. (SPPI) - Spectrum Pharmaceuticals Receives FDA Approval for Rolvedon (eflapegrastim-xnst) Injection.
Spectrum Pharmaceuticals Inc - Commercial Team Ready to Launch With Product Available in Q4.